tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CH:NOVN Stock Latest News

Pan Tumor Rollover Study: A Key Update on Long-term Cancer Treatment
Company AnnouncementsPan Tumor Rollover Study: A Key Update on Long-term Cancer Treatment
2h ago
BMY
NVS
Amgen and Novartis’s Erenumab Study: A Potential Game-Changer in Pediatric Migraine Treatment
PremiumCompany Announcements
Amgen and Novartis’s Erenumab Study: A Potential Game-Changer in Pediatric Migraine Treatment
5d ago
NVS
AMGN
Morning Movers: PepsiCo gains following second quarter results
PremiumThe Fly
Morning Movers: PepsiCo gains following second quarter results
6d ago
GE
KO
Novartis reports Q2 EPS core $2.42, consensus $2.37
PremiumThe Fly
Novartis reports Q2 EPS core $2.42, consensus $2.37
6d ago
NVS
Novartis sees FY25 sales up high single digits
PremiumThe Fly
Novartis sees FY25 sales up high single digits
6d ago
NVS
Novartis initiating up to $10B share buyback to be completed by YE27
PremiumThe FlyNovartis initiating up to $10B share buyback to be completed by YE27
6d ago
NVS
Novartis announces CFO Kirsch to retire, Mehta to succeed
Premium
The Fly
Novartis announces CFO Kirsch to retire, Mehta to succeed
6d ago
NVS
Novartis: Strong Performance and Strategic Initiatives Justify Buy Rating
Premium
Ratings
Novartis: Strong Performance and Strategic Initiatives Justify Buy Rating
6d ago
NVS
Trump says drug tariffs probable by August 1, semis coming soon, Bloomberg says
PremiumThe Fly
Trump says drug tariffs probable by August 1, semis coming soon, Bloomberg says
7d ago
MU
AMD
Novartis loses bid to block MSN generic of Entresto, Bloomberg says
PremiumThe Fly
Novartis loses bid to block MSN generic of Entresto, Bloomberg says
12d ago
NVS
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
PremiumThe Fly
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
12d ago
AZN
BMY
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
PremiumCompany Announcements
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
14d ago
BMY
NVS
Sironax grants Novartis exclusive option to acquire BDM platform
PremiumThe FlySironax grants Novartis exclusive option to acquire BDM platform
14d ago
NVS
Drugmakers criticize Trump drug price negotiation plan, Bloomberg reports
Premium
The Fly
Drugmakers criticize Trump drug price negotiation plan, Bloomberg reports
15d ago
AZN
BMY
Pharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
Premium
The Fly
Pharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
15d ago
AZN
BMY
Novartis announces Coartem Baby approved by Swissmedic
PremiumThe Fly
Novartis announces Coartem Baby approved by Swissmedic
15d ago
NVS
GSK completes acquisition of efimosfermin alfa from Boston Pharmaceuticals
PremiumThe Fly
GSK completes acquisition of efimosfermin alfa from Boston Pharmaceuticals
16d ago
GSK
NVS
Novartis’ RED4MS Trial: A New Hope for Multiple Sclerosis Treatment?
PremiumCompany Announcements
Novartis’ RED4MS Trial: A New Hope for Multiple Sclerosis Treatment?
20d ago
NVS
Novartis reports GCAptAIN study did not meet primary endpoint
PremiumThe Fly
Novartis reports GCAptAIN study did not meet primary endpoint
20d ago
NVS
Novartis: Strong Growth and Product Performance Amid Valuation Concerns and Generic Competition Risks
PremiumRatingsNovartis: Strong Growth and Product Performance Amid Valuation Concerns and Generic Competition Risks
22d ago
NVS
Novartis completes acquisition of Regulus Therapeutics
Premium
The Fly
Novartis completes acquisition of Regulus Therapeutics
28d ago
NVS
RGLS
Novartis announces expiration of Regulus Therapeutics tender offer
Premium
The Fly
Novartis announces expiration of Regulus Therapeutics tender offer
28d ago
NVS
RGLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >